In terms of the Code of Conduct to regulate, monitor and report Trading by Insiders of the company, Albert David has informed that the Trading Window for purchase/sale/dealing in the shares of the Company, shall remain closed for Insiders/Designated Persons of the Company (and their immediate relatives) commencing from Sunday, the 1st October, 2023. The Trading Window will open after 48 hours from the declaration of the Unaudited Financial Results of the Company for the 2nd quarter and half year ended on 30 September, 2023. The date of the Board meeting of the Company for consideration and approval of Unaudited Financial Results for the 2nd quarter and half year ended 30th September, 2023 will be intimated in due course. The aforesaid information is also available on the website of the Company at www.albertdavidindia.com.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |